Thursday, April 22, 2021

Tag: OTCQX

A Marriage of HealthTech and FinTech in a Biotech driven Economy

Currently, the analyst consensus on Avadel Pharmaceuticals is a Strong Buy with an average price target of $20.25, a 167.9% upside from current levels. In a report issued on March 1, Oppenheimer also maintained a Buy rating on the stock with a $19.00 price target

CurrencyWorks (CWRK) NFT Platform Update

CurrencyWorks (CWRK) NFT Platform Update

BTCS (BTCS) Expands its Ethereum 2.0 Staking Operation to 200 Nodes

BTCS (BTCS) Expands its Ethereum 2.0 Staking Operation to 200 Nodes

Rainmaker Worldwide (RAKR) Removes $775,000 in Outstanding Promissory Notes, Loans and...

Rainmaker Worldwide (RAKR) Removes $775,000 in Outstanding Promissory Notes, Loans and Debt

BOON Industries (BNOW) Continues to Expand Distribution of DiOx+ Into New...

BOON Industries (BNOW) Continues to Expand Distribution of DiOx+ Into New Verticals

New to The Street is now New To Newsmax Sundays

A new show is coming to Newsmax Sundays.  New To The Street is the name of the show and it will highlight up and coming businesses and interview their owners and will take over their high-traffic 10:00 AM EST time slot.

ISW Holdings (ISWH) Continues Anti-Dilution Agenda by Eliminating Major Convertible Note

ISW Holdings (ISWH) Continues Anti-Dilution Agenda by Eliminating Major Convertible Note

MasterBeat Corporation’s (MSTO) JTEC AutoWorld to Incorporate Amazon and eBay Listings

MasterBeat Corporation's (MSTO) JTEC AutoWorld to Incorporate Amazon and eBay Listings

BTCS (BTCS) Now Producing Revenue from all 100 Ethereum 2.0 Nodes

BTCS (BTCS) Now Producing Revenue from all 100 Ethereum 2.0 Nodes

Innovative Payment Solutions (IPSI) Announces Capital Raise of $950,000

Innovative Payment Solutions (IPSI) Announces Capital Raise of $950,000